136 related articles for article (PubMed ID: 16937474)
1. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study.
Hajiani E; Hashemi J; Masjedizadeh R; Shayesteh AA; Idani E; Rajabi T
World J Gastroenterol; 2006 Aug; 12(30):4884-7. PubMed ID: 16937474
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study.
Alavian SM; Gholami B; Masarrat S
J Gastroenterol Hepatol; 2002 Oct; 17(10):1092-7. PubMed ID: 12201870
[TBL] [Abstract][Full Text] [Related]
3. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan.
Hajiani E; Masjedizadeh R; Hashemi J; Azmi M; Rajabi T
World J Gastroenterol; 2006 Nov; 12(43):7025-8. PubMed ID: 17109499
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C infection in risk groups.
Ahmetagić S; Muminhodzić K; Cickusić E; Stojić V; Petrović J; Tihić N
Bosn J Basic Med Sci; 2006 Nov; 6(4):13-7. PubMed ID: 17177641
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran.
Makhlough A; Jamshidi M; Mahdavi MR
Singapore Med J; 2008 Nov; 49(11):921-3. PubMed ID: 19037560
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
[TBL] [Abstract][Full Text] [Related]
10. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
Sookoian S; Castaño G; Castiglioni T; Pilar S; Viudez P; González J; Frider B
Medicina (B Aires); 1997; 57(6):699-707. PubMed ID: 9674191
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).
Alavi SM; Alavi L
J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860
[TBL] [Abstract][Full Text] [Related]
12. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos.
Balogun TM; Akinsete I; Durosinmi MA
Niger Postgrad Med J; 2012 Mar; 19(1):36-9. PubMed ID: 22430600
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and risk factors for hepatitis C virus infection among blood donors in Serbia: A multicentre study.
Mitrovic N; Delic D; Markovic-Denic L; Jovicic M; Popovic N; Bojovic K; Simonovic Babic J; Svirtlih N
Dig Liver Dis; 2015 Jul; 47(7):572-6. PubMed ID: 25882212
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran.
Amiri ZM; Shakib AJ; Toorchi M
East Mediterr Health J; 2005 May; 11(3):372-6. PubMed ID: 16602456
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
Bokharaei-Salim F; Keyvani H; Esghaei M; Zare-Karizi S; Dermenaki-Farahani SS; Hesami-Zadeh K; Fakhim S
J Med Virol; 2016 Nov; 88(11):1960-6. PubMed ID: 27463051
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht.
Ansar MM; Kooloobandi A
J Viral Hepat; 2002 Sep; 9(5):390-2. PubMed ID: 12225335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
